Judith Greciet , CEO, Onxeo 00:00:00
Onxeo is a clinical-stage biotechnology company developing novel oncology drugs targeting tumor DNA-binding functions.
Onxeo is a clinical-stage biotechnology company developing novel oncology drugs targeting tumor DNA-binding functions.